Batavia Biomanufacturing

Batavia Biomanufacturing provides state-of-the-art contract development and manufacturing services specializing in viral vectors, vaccines, recombinant proteins, and oncolytic viruses. Its new Leiden facility offers end-to-end solutions including upstream/downstream processing, drug product formulation, aseptic filling/packaging under EU GMP standards with capacity up to hundreds of millions of vaccine doses annually. The company leverages advanced proprietary platforms like HIP-Vax® to accelerate timelines while maintaining high quality standards. It plays a critical role in pandemic preparedness and global health by supporting rapid scale-up from early development through commercial supply.